A recent collaboration between federal agencies and Kaiser Permanente funded by the Centers for Disease Control (CDC) found severe health risks in the first three weeks after receiving an mRNA vaccine from either Pfizer-BioNTech or Moderna were no more common compared with 22-42 days later. The study, titled “Surveillance for Adverse Events After COVID-19 mRNA Vaccination,” was published on September 3 in JAMA Network under the direction of lead author Nicola Klein MD, Ph.D., Kaiser Permanente Vaccine Study Center’s Director and principal investigator of the CDC’s Vaccine Safety Datalink (VSD) COVID-19 rapid cycle analysis.
The study follows a March 2020 announcement of a partnership between Kaiser Permanente and the CDC Foundation—a nonprofit organization whose stated mission is to “mobilize philanthropic and private-sector resources to support the work of the Centers for Disease Control and Prevention (CDC).”
CDC gets most funding from CDC foundation a non profit. Go down the rabbit hole…t.co/GNiP6O4m7B
GAVI is running the show, a Gates collaboration and most non profit. The whole world is involved, corruption is deep. pic.twitter.com/1sS8R9009B
— MAGS (@maggi54) August 29, 2019